NEXENTIS TECHNOLOGIES INC. Disposal Group, Including Discontinued Operation, Liabilities, Current
NEXENTIS TECHNOLOGIES INC. (NXTS) had Disposal Group, Including Discontinued Operation, Liabilities, Current of $194.00 thousand as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent · last filed 2026-08-13
- 2025-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $194.00K.
- 2024-12-31: Disposal Group, Including Discontinued Operation, Liabilities, Current $195.00K; Disposal Group, Including Discontinued Operation, Liabilities, Current as first filed $103.00K.
| Period end | Disposal Group, Including Discontinued Operation, Liabilities, Current | Disposal Group, Including Discontinued Operation, Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $194.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $195.00K 10-K · filed 2026-03-31 | $103.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |